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ABSTRACT: G protein βγ subunits play essential roles in
regulating cellular signaling cascades, yet little is known about
their distribution in tissues or their subcellular localization.
While previous studies have suggested speciﬁc isoforms may
exhibit a wide range of distributions throughout the central
nervous system, a thorough investigation of the expression
patterns of both Gβ and Gγ isoforms within subcellular
fractions has not been conducted. To address this, we applied a
targeted proteomics approach known as multiple-reaction
monitoring to analyze localization patterns of Gβ and Gγ
isoforms in pre- and postsynaptic fractions isolated from
cortex, cerebellum, hippocampus, and striatum. Particular Gβ and Gγ subunits were found to exhibit distinct regional and
subcellular localization patterns throughout the brain. Signiﬁcant diﬀerences in subcellular localization between pre- and
postsynaptic fractions were observed within the striatum for most Gβ and Gγ isoforms, while others exhibited completely unique
expression patterns in all four brain regions examined. Such diﬀerences are a prerequisite for understanding roles of individual
subunits in regulating speciﬁc signaling pathways throughout the central nervous system.
Heterotrimeric G proteins play essential roles in cellularcommunication by transducing extracellular signals from
G protein-coupled receptors (GPCRs) to a wide range of
downstream eﬀectors. The ﬁdelity of this process depends in
part upon the G protein itself, as it requires guanine nucleotide-
binding α subunits to exchange GDP for GTP and reversibly
dissociate from βγ dimers before each can interact with
eﬀectors.1 Originally, signaling was thought to be mediated
solely through Gα subunits;2 however, Gβγ complexes are now
widely recognized as independent signaling molecules, with
eﬀectors such as adenylyl cyclase, phospholipase C-β, PI 3-
kinase, and components of the mitogen-activated protein kinase
cascade.3−8 Additional eﬀectors such as voltage-gated calcium
and potassium channels, as well as members of the exocytotic
machinery, regulate membrane voltage and neurotransmitter
release.9−17 With such diversity, it is hardly surprising that Gβγ
subunits make up a strongly expressed, structurally diverse
family, with 5 and 12 genes encoding 5 β and 12 γ protein
subunits, respectively.18,19 Historically, speciﬁcity has largely
been attributed to the α subunits as only modest functional
diﬀerences were observed in the ability of βγ isoform
combinations to regulate eﬀectors in vitro.20,21 More recent
evidence indicates this may not be the case in intact cells,
however, as studies have suggested very speciﬁc roles for Gβ
and Gγ isoforms.22−27 However, while speciﬁc receptors and
eﬀectors may utilize unique complements of G protein α, β,
and γ subunits, we have little understanding of which G protein
heterotrimers exist in vivo, the factors controlling their
distribution in tissues, their subcellular expression, or their
functional relevance in the context of the whole organism. To
this end, a greater understanding of the tissue localization and
subcellular distribution of Gβγ isoforms will be of particular
importance in determining which of the many possible
combinations are likely to occur physiologically, what roles
each may play in regulating signaling cascades, and their impact
in disease.
The majority of G protein β and γ subunits have been
detected in the central nervous system (CNS).28−34 Our
understanding of their distributions largely stems from in situ
hybridization studies; speciﬁcally, RNAs from some β and γ
isoforms exhibit wide distributions, while others show
expression more restricted to speciﬁc brain regions and cell
types, possibly reﬂecting unique functions.35−40 Although a few
studies have examined protein expression,36,39−42 eﬀorts at this
level have been less reliable as the high level of sequence
identity between isoforms has limited the development of
reliable subunit speciﬁc reagents.43 Proteomic analysis oﬀers a
powerful way to deepen our understanding of the regional and
subcellular localization patterns of Gβγ isoforms as they can be
undertaken using endogenous tissue without the need for
isoform speciﬁc antibodies. Studies examining synaptic
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proteomes to date have largely focused on analyzing the global
expression of proteins involved in synaptic functions,44−52 and
no study has yet sought to speciﬁcally examine G protein
localization patterns. As a result, while a few β and γ isoforms
have been identiﬁed or even localized to subcellular fractions in
discovery-based experiments,53−57 the majority have yet to be
described. Such studies demonstrate that even at isolated nerve
endings, cells express large numbers of proteins, making
identiﬁcation of all of the proteins in a sample problematic.
Further, highly abundant proteins may mask those expressed at
lower levels. To overcome these problems, we applied a
targeted proteomics approach known as multiple-reaction
monitoring (MRM),58,59 which allowed us to accurately
identify unique G protein isoforms in complex mixtures.
Using this approach, we analyzed regional and subcellular
localization patterns of Gβ and Gγ isoforms in diﬀerent brain
regions. Interestingly, we found that these subunits exhibit
distinct regional and subcellular localization patterns through-
out the CNS, suggesting roles for individual subunits in
regulating speciﬁc signaling pathways.
■ MATERIALS AND METHODS
Protein Standards. Gβ1γ1 was puriﬁed from bovine retina
as described previously.60 Recombinant Gβ1γ2 and Gβ5γ2 were
expressed in Sf9 cells and puriﬁed via a His6-tagged Gγ2 using
nickel-nitrilotriacetic acid aﬃnity chromatography (Sigma-
Aldrich, St. Louis, MO). Human Gγ subunit cDNAs for Gγ4,
Gγ5, Gγ7, Gγ11, and Gγ13 were subcloned by polymerase chain
reaction from pcDNA3.1+ clones (Missouri S&T cDNA
Resource Center) into pGEX-6p-1 (GE Healthcare). The
sequences of the resultant vectors, hGgamma(x).pGEX-6p-1,
were veriﬁed, and GST fusion proteins were expressed in
Rosetta Competent Cells (EMD Millipore). After induction
with 1 mM IPTG followed by a 4 h incubation at 37 °C, the
resultant Gγ proteins were batch puriﬁed using Glutathione
Sepahrose 4 Fast Flow (GE Healthcare) and eluted with 10
mM reduced free acid glutathione (Calbiochem).
Animals. Adult, male C57Bl6/J mice were decapitated, and
the cortex, cerebellum, neostriatum (termed the striatum), and
hippocampus were dissected, frozen on dry ice, and stored at
−80 °C until they were processed. To minimize post-mortem
diﬀerences, all brain regions were dissected at the same time
and processed in parallel. All animal protocols were conducted
in accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes
of Health and were approved by the Vanderbilt Institutional
Animal Care and Use Committee.
Antibodies. The following primary antibodies were used for
immunoblotting (dilutions indicated): rabbit anti-Gβ (Santa
Cruz, catalog no. sc-378, 1:15000), mouse anti-N-methyl-D-
aspartate receptor-1 (NMDAR1) (BD Pharmingen, catalog no.
556308, 1:2000), mouse anti-postsynaptic density-95 (PSD-95)
(Neuromab, catalog no. 75-028, 1:20000), mouse anti-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Milli-
pore, catalog no. MAB374, 1:20000), and mouse anti-syntaxin-
1 (Santa Cruz, catalog no. sc-12736, 1:2000). Horseradish
peroxidase-conjugated secondary antibodies were obtained
from Perkin-Elmer and used at the following dilutions: goat
anti-rabbit (1:20000) and goat anti-mouse (1:10000 for
NMDAR1 and syntaxin and 1:20000 for PDS-95 and
GAPDH).
Synaptosome Preparation and Subcellular Fractiona-
tion. Subcellular fractions were prepared as previously
described.61 Brieﬂy, four whole mouse cortex (CTX),
cerebellum (CRB), striatum (Str), or hippocampus (Hippo)
samples were pooled and homogenized in 10 mL of a 0.32 M
sucrose solution [0.32 M sucrose, 4.2 mM potassium 4-(2-
hydroxyethyl)-1-piperazineethanesulfonate (HEPES) (pH 7.4),
0.1 mM CaCl2, 1 mM MgCl2, 1.54 μM aprotinin, 10.7 μM
leupeptin, 0.95 μM pepstatin, and 200 μM phenylmethane-
sulfonyl ﬂuoride (PMSF)]. Homogenates were centrifuged at
1000g and 4 °C for 10 min to pellet nuclei and membrane
debris before supernatants were transferred to clean conical
tubes. Pellets were resuspended in 10 mL of 0.32 M sucrose;
the centrifugation step was repeated, and supernatants were
combined. Following mixing, supernatants were centrifuged at
10000g and 4 °C for 20 min to produce crude synaptosome
preparations. Supernatants were discarded and pellets gently
resuspended in 4 mL of hypotonic lysis buﬀer [20 mM Tris
(pH 6.0), 0.1 mM CaCl2, 1 mM MgCl2, 1% Triton X-100, 1.54
μM aprotinin, 10.7 μM leupeptin, 0.95 μM pepstatin, and 200
μM PMSF] before being incubated on ice for 20 min to lyse
membranes. Lysates were cleared via ultracentrifugation at
100000g and 4 °C for 2 h in a SW-55 Ti rotor (Beckman
Coulter) and supernatants (consisting of the “perisynaptic/
cytosolic” fraction) transferred to clean conical tubes. Pellets
were resuspended in 1 mL of Tris buﬀer [20 mM Tris (pH
8.0), 1% Triton X-100, 1.54 μM aprotinin, 10.7 μM leupeptin,
0.95 μM pepstatin, and 200 μM PMSF] and incubated on ice
for 20 min. Lysates were centrifuged at 10000g and 4 °C for 30
min and supernatants containing enriched presynaptic fractions
collected. Finally, pellets were resuspended in 200 μL of a 1×
phosphate-buﬀered saline/1% SDS mixture and centrifuged at
10000g and 4 °C for 30 min. Supernatants containing enriched
postsynaptic fractions were collected. Protein concentrations
were determined with a BCA assay kit (Pierce).
Immunoblot Analysis. To examine the enrichment of pre-
and postsynaptic fractions, Western blot analysis was
performed; 7 μg of each fraction was diluted in 4× sodium
dodecyl sulfate−polyacrylamide gel electrophoresis (SDS−
PAGE) sample buﬀer containing 100 mM dithiothreitol, heated
for 5 min at 70 °C, and resolved on 10 or 15% SDS−PAGE
gels. Proteins were transferred electrophoretically to a nitro-
cellulose membrane in cold transfer buﬀer consisting of 200 mL
of 3-(cyclohexylamino)-1-propanonesulfonic acid (CAPS), 200
mL of methanol, and 1600 mL of water. Following transfer,
membranes were stained with Ponceau and cut between
appropriate molecular weight markers. Membranes were
blocked with slight agitation for 1 h in a buﬀer of Tris-buﬀered
saline (TBS) with 5% milk and 0.1% Tween 20 (Sigma-
Aldrich). Membranes were then washed ﬁve times for 5 min in
TBS with 0.1% Tween 20 on a shaker before being incubated
with the appropriate primary antibodies in TBS with 5% milk
and 0.2% Tween 20 on a shaker table at 4 °C overnight. The
next day, membranes underwent ﬁve 5 min washes on a shaker
table in TBS with 0.1% Tween 20 before the appropriate
secondary antibodies were diluted into TBS with 5% milk and
0.2% Tween 20 followed by gentle agitation on a shaker with
the membranes for 1 h at room temperature. Finally,
membranes were washed three times for 10 min in TBS with
0.1% Tween 20 followed by two 15 min washes in TBS.
Immunoblots were developed using Western Lightning
Chemiluminescence Reagent Plus (NEL104) from Perkin-
Elmer as per their published protocols. Imaging was conducted
using a Bio-Rad imager.
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Development and Validation of Targeted Mass
Spectrometry Methods. Puriﬁed Gβγ isoforms or enriched
protein pre- and postsynaptic fractions were separated by
SDS−PAGE (15% acrylamide) and stained with colloidal
Coomassie Blue (Invitrogen). Gel bands corresponding to the
molecular weights of Gβ and Gγ subunits were excised,
chopped into 1 mm3 pieces, reduced with dithiothreitol,
alkylated with iodoacetamide, and digested with trypsin.
Individual G protein subunit digests from puriﬁed proteins
were analyzed via nanoﬂow reverse phase liquid chromatog-
raphy−tandem mass spectrometry (LC−MS/MS) on an LTQ-
Orbitrap XL mass spectrometer (Thermo Scientiﬁc), while
those from enriched protein synaptic fractions were analyzed
on an LTQ-Orbitrap Velos mass spectrometer (Thermo
Scientiﬁc). Peptides were loaded onto a capillary reverse
phase analytical column (360 μm outside diameter × 100 μm
inside diameter) using an Eksigent NanoLC high-performance
liquid chromatography system and autosampler. The analytical
column was packed with 20 cm of C18 reverse phase material
(Jupiter, 3 μm beads, 300 Å, Phenomenex), equipped with a
laser-pulled emitter tip. Peptides were gradient-eluted at a ﬂow
rate of 500 nL/min, and the mobile phase solvents consisted of
0.1% formic acid and 99.9% water (solvent A) and 0.1% formic
acid and 99.9% acetonitrile (solvent B). A 45 min gradient was
performed for puriﬁed G protein samples, consisting of the
following: from 0 to 10 min, 2% B (during sample loading);
from 10 to 28 min, 2 to 40% B; from 28 to 34 min, 40 to 90%
B; from 34 to 35 min, 90% B; from 35 to 37 min, 90 to 2% B;
from 37 to 45 min, 2% B (column equilibration). In
comparison, a 90 min gradient was performed for G protein
samples isolated from enriched protein presynaptic fractions
consisting of the following: from 0 to 10 min, 2% B; from 10 to
50 min, 2 to 35% B; from 50 to 60 min, 35 to 90% B; from 60
to 65 min, 90% B; from 65 to 70 min, 90 to 2% B; from 70 to
90 min, 2% B. Upon gradient elution, peptides were mass
analyzed on an LTQ Orbitrap XL or LTQ Orbitrap Velos mass
spectrometer (Thermo Scientiﬁc). The instruments were
operated using a data-dependent method with dynamic
exclusion enabled. Full scan (m/z 300−2000) spectra were
acquired with the Orbitrap as the mass analyzer (resolution of
60000), and the 5 most abundant (LTQ Orbitrap XL) or 16
most abundant ions (LTQ Orbitrap Velos) in each MS scan
were selected for fragmentation via collision-induced dissoci-
ation (CID) in the LTQ. For selected LC−MS/MS analyses,
the LTQ Orbitrap Velos was operated using a combination
method of data-dependent and targeted scan events. Targets
were of speciﬁc m/z values corresponding to unique Gβ or Gγ
peptides selected from theoretical in silico digestions of the G
protein subunits. Peptides were identiﬁed via database
searching with Sequest62 (Thermo Scientiﬁc). Tandem mass
spectra were searched against Bos taurus, Mus musculus, or
Homo sapiens subsets of the UniprotKB protein database
(http://www.uniprot.org), and search results were assembled
using Scaﬀold version 3.0 (Proteome Software). Although
isoforms were puriﬁed from bovine retina, as well as cloned
using human sequences, peptides unique to each Gβγ isoform
being monitored were shown to be identical across all three
species, allowing use of these proteins for assay development.
All searches were conﬁgured to use variable modiﬁcations of
carbamidomethylation on cysteine and oxidation of methio-
nine. The selected peptides from each G protein β and γ
subunit were validated via manual interrogation of the raw
tandem mass spectra using QualBrowser software (Xcalibur
version 2.1.0, Thermo Scientiﬁc), and as an additional
validation criterion, the observed monoisotopic m/z value
was required to be within 5 ppm of the theoretical m/z value
for a given peptide. Identiﬁed peptides unique to G protein
isoforms were selected, and their MS/MS spectra were
examined to select precursor−product ion transitions for
targeted MRM experiments. MRM methods were generated
in Skyline63 before being exported and employed for G protein-
targeted experiments on a TSQ Vantage triple quadrupole mass
spectrometer (Thermo Scientiﬁc). Unscheduled MRM runs
were performed on puriﬁed Gβγ isoforms when available, as
well as enriched pre- and postsynaptic fractions from mouse
cortex, to evaluate intensities of precursor and product ions
identiﬁed in early discovery proteomic runs. The resulting
MRM data were imported and analyzed in Skyline. Extracted
ion chromatographic peaks were manually interrogated and
correct peaks chosen on the basis of retention times, how well
the relative distribution of transition ions matched those from
discovery experiments, and dot plot values. Dot plot values
were calculated by comparison of transition ion intensities in
MRM data relative to product ion intensities observed in
tandem mass spectra acquired in LTQ-Orbitrap discovery
experiments. Following validation, precursor and product ion
lists were reﬁned to include only the optimal precursor and
transitions necessary to accurately identify each G protein
isoform. Reﬁned methods were required to include at least two
distinct peptides for each G protein isoform, as well as three
transitions for each peptide being monitored. These data and
criteria were then used to generate scheduled MRM methods
that could be applied to pre- and postsynaptic fractions from
diﬀerent brain regions.
Application of Targeted Proteomics Methods to
Enriched Synaptic Fractions. Once reﬁned, scheduled
MRM methods were applied to in-gel-digested proteins from
mouse brain-enriched pre- and postsynaptic fractions isolated
from cortex, cerebellum, hippocampus, and striatum; 50 μg of
total protein from each fraction was separated by SDS−PAGE
for each brain region and digested as described. Gβ peptides
were analyzed by a single 60 min scheduled MRM analysis,
while Gγ peptides were split into two 60 min scheduled MRM
runs. Biological samples were randomized to ensure any drift in
assay performance would not aﬀect subsets disproportionately.
Brieﬂy, utilizing a trap column setup, peptides were ﬁrst loaded
onto a 100 μm × 4 cm C18 reverse phase column, which was
connected in line to a 20 cm × 100 μm (Jupiter, 3 μm, 300 Å)
analytical column. Peptides were gradient-eluted into a TSQ-
Vantage instrument (Thermo Scientiﬁc) using a nano-
electrospray source. Peptides were resolved using an aqueous
to organic gradient with a 60 min total cycle time. Scheduled
instrument methods encompassing a 10 min window around
the measured retention time along with calculated collision
energies were created using Skyline. The Q1 peak width
resolution was set to 0.7; the collision gas pressure was 1
mTorr, and a cycle time of 5 s was utilized. The resulting RAW
instrument ﬁles were imported into Skyline for peak-picking
and quantitation. Data analysis using Skyline was performed to
assess enrichment of individual G protein subunits in pre- or
postsynaptic fractions. Transition ion intensities were summed
for each precursor, and these data were used to generate
extracted ion chromatographic peaks of co-eluting transitions.
As described previously, chromatographic peaks were manually
interrogated and correct peaks chosen on the basis of retention
times, dot plot values, and relative distributions of transition
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ions. For peptides where a correct peak could conﬁdently be
chosen, a signal-to-noise (S/N) ratio of at least 30 was required
to be included in analyses; those that did not meet this criterion
were removed from further analyses. Four internal reference
peptides, SSAAPPPPPR, TASEFDSAIAQDK, ELGQSGVDT-
YLQTK, and LTILEELR (Table 1), were used to evaluate drift
in assay performance and to allow data to be normalized. Each
reference peptide (5 fmol) was spiked into all samples and
monitored throughout all MRM experiments. BSA controls
were monitored at regular intervals between samples to
evaluate instrument performance. The integrated area under
the curve was calculated for all transitions. Coeﬃcients of
variation (CVs) were calculated for BSA controls and spiked in
reference peptides using the relationship CV = (average total
AUC)/(SD of total AUC), where AUC represents the
integrated area under the curve for all transitions and SD
represents the standard deviation of the total AUC. To allow
comparison between experiments conducted on diﬀerent days,
the integrated area under the curve for each peptide was
normalized relative to the internal reference peptide that was
closest in retention time to it. This generated a normalized total
area for each peptide.
A modiﬁed labeled reference peptide (LRP) method64 was
applied using the internal reference peptides described above to
compare brain regions and subcellular fractions for each G
protein isoform. To evaluate the expression of each G protein
isoform using this method, a ratio between the normalized total
area for each peptide being monitored and the total area for
one internal reference peptide, ELGQSGVSTYLQTK, was
calculated. The ratios for all peptides monitored for a given
isoform were then averaged and the averages plotted for each
protein. Fold diﬀerences were calculated to compare expression
of each G protein isoform in pre- and postsynaptic fractions
within a brain region as well as pre- or postsynaptic fractions
between brain regions. To compare expression within a brain
region, the average normalized total area calculated from the
postsynaptic fraction was divided by the average normalized
total area calculated from the presynaptic fraction of that same
region (e.g., CTX post normalized total area/CTX pre
normalized total area). To compare expression in presynaptic
fractions of diﬀerent brain regions, the average normalized total
area from a presynaptic fraction in one brain area was divided
by the average normalized total area from a presynaptic fraction
from another brain region (e.g., CTX pre normalized total
area/CRB pre normalized total area). This was also done for
comparisons of postsynaptic fractions between brain regions.
Statistical Analysis. To evaluate data for comparison of
brain regions and subcellular fractions, a two-way analysis of
variance (ANOVA) was used to account for diﬀerences in
isoform expression that could be due to their location in the
CNS (i.e., CTX or CRB; termed brain region eﬀect), their
subcellular location (i.e., pre- or postsynaptic; termed the
fraction eﬀect), or a combination of the two (termed the
interaction eﬀect). To determine where speciﬁc diﬀerences in
expression occurred, a Tukey post hoc test was used. In the
case of Gβ5, data were evaluated using an unpaired t test.
■ RESULTS
Synaptosome Subcellular Fractionation Eﬃciency. To
assess the localization patterns of diﬀerent G protein isoforms,
we made use of a brain synaptosomal preparation and
subcellular fractionation protocol that would allow us to reduce
sample complexity (Figure 1A). Synaptosomes are a widely
used preparation for studying synaptic biochemistry as they
contain the complete presynaptic terminus, including mito-
chondria and synaptic vesicles, as well as the postsynaptic
Table 1. Internal Reference Peptides and MRM Transitions Added to All G Protein Samples
peptide sequence precursor m/z charge collison energy product ion m/z
SSAAPPPPPR 493.7683 +2 18 287.1728, 379.2327,
476.2855, 670.3910
TASEFDSAIAQDK 695.8324 +2 24 740.4028, 855.4298,
1002.4982,
1218.5728
ELGQSGVDTYLQTK 773.8956 +2 26 761.4286, 876.4553,
1032.5452, 1119.5772
LTILEELR 498.8018 +2 18 214.1306, 427.2539,
669.3805, 782.4646
Figure 1. Distribution of marker proteins in pre- and postsynaptic fractions. (A) Experimental protocol for the isolation of synaptosomes from
mouse brain tissue and the enrichment of pre- and postsynaptic fractions. (B) Representative immunoblots for NMDAR1, postsynaptic density 95
(PSD-95), GAPDH, syntaxin-1, and Gβ isolated from enriched pre- and postsynaptic fractions of adult mice.
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membrane and postsynaptic density (PSD).44,53 To verify the
eﬃciency of our fractionation protocol, we examined the
enrichment of well-established synaptic markers in our pre- and
postsynaptic fractions. Protein (7 μg of total protein) from each
isolated fraction was separated on SDS−PAGE gels, electro-
blotted onto nitrocellulose membranes, and immunostained
with antibodies against NMDAR1, PSD-95, GAPDH, syntaxin-
1, and Gβ. Figure 1B reveals the high level of enrichment of
NMDAR1 and PSD-95 in the postsynaptic fraction, whereas
the presynaptic fraction is enriched with syntaxin-1. Although
syntaxin-1 is thought to be primarily concentrated at the site of
neurotransmitter release in neurons, it has also been shown to
be expressed postsynaptically,65 accounting for its presence in
the postsynaptic fraction following enrichment in this study.
Conversely, GAPDH, a cytosolic protein, shows equal levels of
expression in both fractions, although the level of expression in
pre- and postsynaptic fractions was lower than that seen in
cytosolic fractions (data not shown). Similarly, Gβ was
expressed equally in both pre- and postsynaptic factions using
a pan-Gβ antibody (Figure 1B).
Development and Validation of Targeted Mass
Spectrometry Methods. Target peptides and transitions for
MRM studies were obtained by analyzing puriﬁed, recombinant
Gβγ proteins (Gβ1, Gβ5, Gγ2, Gγ4, Gγ5, Gγ7, Gγ11, and Gγ13)
when available, as well as enriched pre- and postsynaptic
fractions from mouse cortex. Figure 2A illustrates a schematic
of the workﬂow for targeted MRM development. In silico
tryptic digests were initially performed and peptides that were
unique to a single G protein isoform preselected. Peptides were
then further screened for uniqueness by performing a protein
basic local alignment search tool search. Only precursor
peptides unique to a single G protein isoform and not found
in protein sequences belonging to related or unrelated proteins
were chosen (Table 2). Following tryptic digestion, extracted
peptides from puriﬁed G protein samples were initially analyzed
on an LTQ-Orbitrap XL mass spectrometer, while those from
enriched pre- and postsynaptic fractions were analyzed on an
LTQ-Orbitrap Velos mass spectrometer. Data-dependent LC−
MS/MS runs identiﬁed >200 proteins in synaptic fractions
from gel regions corresponding to the expected molecular
weight of Gβ and Gγ subunits (data not shown). From these
initial experiments, peptides corresponding to four of the ﬁve
Gβ isoforms (Gβ1, Gβ2, Gβ4, and Gβ5) were identiﬁed and
validated, as well as eight of the Gγ isoforms (Gγ2, Gγ3, Gγ4,
Gγ5, Gγ7, Gγ11, Gγ12, and Gγ13). Unique peptides correspond-
ing to Gβ3, Gγ8, and Gγ10 were not identiﬁed in subcellular
Figure 2. Development and validation of targeted mass spectrometry methods. (A) Workﬂow for the development and validation of multiple-
reaction monitoring (MRM) methods. (B) LC−MS/MS identiﬁcation of the Gβ1 peptide, ACADATLSQITNNIDPVGR. The top panel shows the
mass spectrum of peptides eluting at 42 min. The peak at m/z 1008.5 (blue) corresponds to the [M + 2H]2+ precursor ion of the Gβ1 peptide. The
inset shows the base peak chromatogram; the asterisk denotes the peak of the peptide at 42 min. The bottom panel shows the MS/MS spectrum of
the ion at m/z 1008.5. Observed b- and y-type product ions are labeled, and sites of amide bond cleavage are denoted with brackets. Circles indicate
product ions imported into initial MRM methods for evaluation. (C) Chromatographic traces for each transition generated from fragmentation of
the [M + 2H]2+ precursor (m/z 1008.5) to its corresponding y product ions (y4−y9; diﬀerent colors) during MRM. Transition peaks were readily
observed following analysis of puriﬁed Gβ1 (top), and equivalent transitions were evident upon analysis of pre- and postsynaptic fractions isolated
from mouse brain cortical tissue (middle and bottom, respectively).
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fractions during discovery experiments. Polymorphisms in the
Gβ3 gene have been shown to dramatically alter its amino acid
sequence;66 Gγ8 is expressed only in olfactory and vomeronasal
neuroepithelia,67 and Gγ10 is only a minor isoform in the
CNS.41 Such factors may account for why we were unable to
identify unique peptides using published sequences. These
isoforms were excluded from the targeted LC−MS/MS
analysis. Further, Gγ1 was not investigated, as its expression is
limited to the retina.68 Figure 2B shows a representative
spectrum for the LC−MS/MS identiﬁcation of a Gβ1 peptide,
ACADATLSQITNNIDPVGR. Gβγ precursor peptides with
appropriate m/z values (<5 ppm relative to theoretical values)
were fragmented to generate MS/MS spectra. Unique
precursor peptides identiﬁed in data-dependent runs were
veriﬁed by manual interrogation of the MS/MS spectra and
product ions ranked on the basis of intensity. Discovery
experiments were leveraged such that isoform speciﬁc peptides
showing both a strong signal and fragmentation were chosen as
precursors and transitions for monitoring via MRM. Chromato-
graphic peaks were selected using criteria previously described.
If puriﬁed samples were available, the RTs of peptides identiﬁed
in complex mixtures had to match the RTs for those of the
puriﬁed sample (Figure 2C). Similarly, relative intensities of
transitions were required to mirror those of puriﬁed samples
Table 2. Precursor Peptides and MRM Transitions Used for the Identiﬁcation of Gβ and Gγ Isoforms in Enriched Pre- and
Postsynaptic Fractionsa
G protein
isoform
sequence
position peptide sequence
precursor
m/z charge
collison
energy product ion m/z
Gβ1 24−42 (K)ACADATLSQITNNIDPVGR(I) 1008.4944 +2 33 428.2616, 543.2885, 884.4585, 985.5061
138−150 (R)ELAGHTGYLSCCR(F) 762.3401 +2 26 641.2768, 858.3597, 915.3811, 1016.4288
198−209 (R)LFVSGACDASAK(L) 613.2977 +2 21 483.2215, 779.3352, 866.3673, 965.4357
284−301 (R)LLLAGYDDFNCNVWDALK(A) 1064.0144 +2 35 632.3402, 894.3883, 950.9304, 1119.5252
Gβ2 24−42 (K)ACGDSTLTQITAGLDPVGR(I) 966.4782 +2 32 428.2616, 543.2885, 713.3941, 885.4789
(K)ACGDSTLTQITAGLDPVGR(I) 644.6546 +3 27 428.2616, 543.2885, 713.3941, 885.4789
198−209 (R)TFVSGACDASIK(L) 628.3030 +2 22 504.2449, 821.3822, 908.4142, 1007.4826
257−280 (R)ADQELLMYSHDNIICGITSVAFSR(S) 914.1072 +3 37 409.2194, 480.2565, 666.3570, 767.4046
(R)ADQELLMYSHDNIICGITSVAFSR(S) 919.4388 +3 37 409.2194, 480.2565, 666.3570, 937.5102
Gβ4 198−209 (R)TFVSGACDASSK(L) 615.2770 +2 21 491.2189, 667.2716, 795.3301, 882.3622,
981.4306
305−314 (R)SGVLAGHDNR(V) 513.2598 +2 18 391.6988, 598.2692, 669.3063, 782.3904
(R)SGVLAGHDNR(V) 342.5089 +3 15 335.1568, 391.6988, 441.2330, 469.7438
Gβ5 45−54 (R)VEALGQFVMK(T) 561.3048 +2 20 709.3702, 822.4542, 893.4913, 1022.5339
(R)VEALGQFVMK(T) 569.3023 +2 20 540.2850, 725.3651, 838.4491, 909.4863
87−97 (K)VIVWDSFTTNK(E) 655.3430 +2 23 679.3515, 812.3785, 998.4578, 1097.5262
280−296 (K)ESIIFGASSVDFSLSGR(L) 886.4467 +2 30 666.3570, 781.3839, 967.4843, 1054.5164
318−327 (R)VSILFGHENR(V) 586.3146 +2 21 493.2643, 612.2848, 759.3533, 872.4373
Gγ2 21−27 (K)MEANIDR(I) 424.7002 +2 16 517.2729, 588.3100, 717.3526
(K)MEANIDR(I) 432.6976 +2 16 517.2729, 588.3100, 717.3526
33−46 (K)AAADLMAYCEAHAK(E) 761.3449 +2 26 715.3192, 878.3825, 1080.4601, 1193.5442
(K)AAADLMAYCEAHAK(E) 769.3423 +2 26 698.3052, 878.3825, 949.4196, 1096.4550
47−62 (K)EDPLLTPVPASENPFR(E) 891.4571 +2 30 769.4223, 917.4476, 1113.5687, 1214.6164
Gγ3 3−17 (K)GETPVNSTMSIGQAR(K) 774.3778 +2 26 431.2361, 544.3202, 630.8219, 681.3457,
950.4724, 1064.5153
(K)GETPVNSTMSIGQAR(K) 782.3752 +2 26 431.2361, 638.8193, 689.3432, 1080.5102
25−31 (K)IEASLCR(I) 424.7184 +2 16 448.2337, 535.2657, 606.3028, 735.3454
Gγ4 3−17 (K)EGMSNNSTTSISQAR(K) 791.8599 +2 27 431.2467, 661.3628, 863.4581, 950.4901
(K)EGMSNNSTTSISQAR(K) 799.8574 +2 27 461.2467, 574.3307, 661.3628, 863.4581
34−50 (K)VSQAASDLLAYCEAHVR(E) 630.6440 +3 26 717.3457, 752.8643, 788.3828, 8959281
51−66 (R)EDPLIIPVPASENPFR(E) 897.4753 +2 30 917.4476, 1113.5687, 1226.6528
Gγ5 28−36 (K)VSQAAADLK(Q) 451.7507 +2 17 260.1969, 358.7005, 588.3352, 803.4258
64−68 (K)VCSFL(-) 625.3014 +2 22 279.1703, 366.2023, 526.2330
Gγ7 19−25 (R)IEAGIER(I) 394.2191 +2 15 474.2671, 545.3042, 674.3468
45−60 (R)NDPLLVGVPASENPFK(D) 848.9489 +2 28 734.4139, 889.4414, 1045.5313, 1144.5997
Gγ11 17−23 (K)MEVEQLR(K) 425.7315 +2 17 416.2616, 545.3042, 644.3726, 773.4152
(K)MEVEQLR(K) 460.7289 +2 17 416.2616, 545.3042, 644.3726, 773.4152
42−47 (K)NYIEER(S) 823.3945 +2 28 278.1135, 304.1615, 391.1976, 520.2402,
Gγ12 5−15 (K)TASTNSIAQAR(R) 560.2913 +2 20 445.2515, 645.3678, 759.4108, 947.4905
23−29 (R)LEASIER(I) 409.2243 +2 15 504.2776, 575.3148, 704.3573
49−64 (R)SDPLLMGIPTSENPFK(D) 873.4426 +2 29 772.4131, 919.4520, 1089.5575, 1220.5980
(R)SDPLLMGIPTSENPFK(D) 881.4400 +2 29 780.4105, 919.4520, 1089.5575, 1236.5929
Gγ13 18−23 (K)YQLAFK(R) 385.2158 +2 15 365.2183, 478.3024, 606.3610
37−44 (K)WIEDGIPK(D) 479.2556 +2 17 244.1656, 414.2711, 529.2980, 658.3406
55−61 (K)NNPWVEK(A) 443.7245 +2 16 276.1554, 386.7030, 658.3559
aBold letters C and M represent carbidomethylation and oxidation of cysteine and methionine, respectively.
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and correlate closely with that seen in discovery experiments
(Figure 2C). Dot plot values were used as an aid to assess how
well MRM results matched MS/MS data obtained with the
Orbitrap. MRM methods were reﬁned to pare down the
number of peptides and transition ions being evaluated. Table 2
shows the list of ﬁnalized precursor peptides and product ions
being monitored in MRM experiments for each G protein
isoform in experimental samples.
Evaluating Regional and Subcellular G Protein Local-
ization Patterns. We next applied our reﬁned MRM method
to subcellular fractions isolated from mouse cortex, cerebellum,
hippocampus, and striatum. All four of the β isoforms (Gβ1,
Gβ2, Gβ4, and Gβ5) being targeted were detected in pre- and
postsynaptic fractions in all four brain regions, as well as six of
the eight γ isoforms (Gγ2, Gγ3, Gγ4, Gγ7, Gγ12, and Gγ13).
Chromatographic peaks of monitored transition ions could not
be conﬁdently identiﬁed for Gγ5 and Gγ11 despite the fact that
target peptides had been validated using recombinant proteins
in the development phase. Gγ11 is thought to be a minor
isoform in the brain with the highest level of expression in lung
and platelets.41 Further, both Gγ5 and Gγ11 undergo post-
translational processing;41,69 this was not included in method
development and could explain why peptides could not be
conﬁdently identiﬁed in CNS fractions. Neither isoform was
included in analyses. No signiﬁcant variance in system
performance was observed across quality control (QC) runs
as measured by examining BSA peptide peak areas across the
experiment or peak area coeﬃcients of variation (CVs) for
replicate QC analyses (Figure 1 of the Supporting Informa-
tion). Similarly, no signiﬁcant drift in assay performance was
observed as measured by monitoring peak areas as well peak
area CVs for internal reference peptides (Figures 2 and 3 of the
Supporting Information). Although stable isotope dilution
(SID) is the gold standard for quantifying protein expres-
sion,64,70 its cost-prohibitive nature prevented its use when
trying to evaluate a large number of G protein isoforms.
Instead, application of an LRP method64 allowed the relative
abundance of G protein isoforms to be examined. With this
method, direct comparisons between isoforms cannot be made;
rather, comparisons are only possible across brain regions and
subcellular fractions for each individual isoform, as described
below. As a result, average normalized areas for each isoform
were each plotted on diﬀerent axes in Figures 3 and 4.
Gβ Isoforms. Subcellular localization patterns were
evaluated for each of the four Gβ isoforms being monitored
by MRM. Although there was a trend toward higher levels of
expression of Gβ1 and Gβ4 in the cortex and cerebellum,
expression levels were not signiﬁcantly diﬀerent within or
across most brain regions for three of the four isoforms (Figure
3A−C). Within the striatum, however, Gβ1, Gβ2, and Gβ4 were
all expressed at signiﬁcantly higher levels in the postsynaptic
fraction than in the presynaptic fraction (Figure 3A−C). An
Figure 3. Gβ isoforms exhibit diﬀerential regional and subcellular localization patterns within the mouse brain. Expression of speciﬁc Gβ isoforms
(A) Gβ1, (B) Gβ2, (C) Gβ4, and (D) Gβ5 in cortex, cerebellum, hippocampus, and striatum. Data for panels A−C were compared by a two-way
ANOVA. The two-way ANOVA results were as follows: (A) Gβ1, interaction eﬀect p = 0.0321; (B) Gβ2, brain region aﬀect p = 0.0362, fraction
eﬀect p = 0.0039, and interaction eﬀect p = 0.0023; (C) Gβ4, fraction eﬀect p = 0.0066. Post hoc analysis was achieved by Tukey’s multiple-
comparison test. *p < 0.05. **p < 0.01. ***p < 0.001. ****p < 0.0001. Data for panel D were evaluated by an unpaired t test (p = 0.01).
Comparison to cortex represented by #, to cerebellum by &, and to hippocampus by $. Signiﬁcance for each symbol as indicated for asterisks. N.D.,
not detected. N = 4 for all brain regions.
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interaction eﬀect was seen for Gβ1 (ANOVA p value = 0.0321),
speciﬁcally, a Gβ1 Str post/Str pre fold diﬀerence of 2.63, with a
p value of <0.05 (Table 1 of the Supporting Information),
whereas there were brain region, fraction, and interaction
eﬀects for Gβ2 [ANOVA p values of 0.0362, 0.0039, and
0.0023, respectively; Gβ2 Str post/Str pre fold diﬀerence of
3.78, with a p value of <0.001 (Table 2 of the Supporting
Information)] and a fraction eﬀect for Gβ4 [ANOVA p value =
0.0066; Str post/Str pre fold diﬀerence of 4.06, with a p value of
<0.05 (Table 3 of the Supporting Information)]. In addition,
the level of postsynaptic expression of Gβ2 was signiﬁcantly
greater in the striatum than in postsynaptic fractions from the
cortex, cerebellum, or hippocampus [Figure 3B; Str post/CTX
post fold diﬀerence of 1.55, with a p value of <0.05; Str post/
CRB post fold diﬀerence of 1.08, with a p value of <0.01; Str
post/Hippo post fold diﬀerence of 2.08, with a p value of <0.05
(Table 2 of the Supporting Information)]. In comparison, Gβ5
was detected in only the striatum on the basis of our peak
criteria and S/N requirements (Figure 3D). As was seen for the
other Gβ isoforms, the level of expression of Gβ5 was
signiﬁcantly higher in the postsynaptic fraction than in the
presynaptic fraction [Figure 3D; Str post/Str pre fold diﬀerence
Figure 4. Gγ isoforms exhibit diﬀerential regional and subcellular localization patterns within the mouse brain. Expression of speciﬁc Gγ isoforms
(A) Gγ2, (B) Gγ3, (C) Gγ4, (D) Gγ7, (E) Gγ12, and (F) Gγ13 in cortex, cerebellum, hippocampus, and striatum. Data were compared by a two-way
ANOVA. The two-way ANOVA results were as follows: (A) Gγ2, brain region eﬀect p = 0.002 and fraction eﬀect p = 0.0035; (B) Gγ3, brain region
eﬀect p = 0.0125 and fraction eﬀect p = 0.0003; (C) Gγ4, brain region eﬀect p = 0.0093, fraction eﬀect p = 0.001, and interaction eﬀect p = 0.04; (D)
Gγ7, brain region eﬀect p < 0.0001, fraction eﬀect p < 0.0001, and interaction eﬀect p < 0.0001; (E) Gγ12, brain region eﬀect p = 0.0304 and fraction
eﬀect p < 0.0001; (F) Gγ13, brain region eﬀect p < 0.0001 and fraction eﬀect p < 0.0001. Post hoc analysis was achieved by Tukey’s multiple-
comparison test. *p < 0.05. **p < 0.01. ***p < 0.001. ****p < 0.0001. Comparison to cortex represented by #, to cerebellum by &, to hippocampus
by $, and to striatum by +. Signiﬁcance for each symbol as indicated for asterisks. N = 4 for all brain regions.
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of 4.07, with a p value of <0.05 (Table 4 of the Supporting
Information)].
Gγ Isoforms. In contrast to the Gβ isoforms, the Gγ
isoforms showed greater diversity in their subcellular and
regional localization patterns. Gγ2, Gγ3, Gγ4, Gγ7, Gγ12, and
Gγ13 were clearly detected in each of the four brain regions
being studied. In the case of Gγ2, no signiﬁcant diﬀerences in
regional or subcellular fractions were observed, except within
the hippocampus. The level of expression of this isoform was
found to be signiﬁcantly greater in the postsynaptic fraction of
the hippocampus than in the cerebellum (Figure 4A). There
were brain region and fraction eﬀects for Gγ2 (ANOVA p
values of 0.002 and 0.0035, respectively), speciﬁcally, a Gγ2
Hippo post/CRB post fold diﬀerence of 3.61, with a p value of
<0.05 (Table 5 of the Supporting Information). Additionally,
there was a trend toward higher levels of expression in the
postsynaptic fraction of the hippocampus and striatum
compared to presynaptic fractions within these same regions
(Figure 4A). Similar patterns of expression were observed for
Gγ3. No signiﬁcant diﬀerences were observed across the four
brain regions. When comparisons were made between
subcellular fractions, however, there was a trend toward higher
levels of expression in postsynaptic fractions, although this was
only signiﬁcant within the striatum (Figure 4B). In this case,
there were also brain region and fraction eﬀects (ANOVA p
values of 0.0125 and 0.0003, respectively), speciﬁcally, a Gγ3 Str
post/Str pre fold diﬀerence of 2.60, with a p value of <0.05
(Table 6 of the Supporting Information). Gγ4 and Gγ7 were
somewhat diﬀerent in that signiﬁcant diﬀerences were observed
in both regional and subcellular expression. There were brain
region, fraction, and interaction eﬀects for both isoforms (Gγ4
ANOVA p values of 0.0093, 0.001, and 0.04, respectively; Gγ7
ANOVA p value of <0.0001 for all three eﬀects). In the case of
Gγ4, the level of postsynaptic expression in the hippocampus
and striatum was found to be signiﬁcantly greater than that in
the cerebellum [Figure 4C; Hippo post/CRB post fold
diﬀerence of 4.00, with a p value of <0.05; Str post/CRB
post fold change of 3.83, with a p value of <0.05 (Table 7 of the
Supporting Information)]. Further, while there was a trend
toward a higher level of expression in the postsynaptic fraction
than in the presynaptic fraction within both the hippocampus
and striatum, it was only signiﬁcant within the striatum [Figure
4C; Str post/Str pre fold diﬀerence of 3.71, with a p value of
<0.05 (Table 7 of the Supporting Information)]. Expression of
Gγ7 was not signiﬁcantly diﬀerent between pre- and
postsynaptic fractions in the cortex, cerebellum, and hippo-
campus. Within the striatum, however, the level of expression
was signiﬁcantly higher in the postsynaptic fraction than in the
presynaptic fraction [Figure 4D; Str post/Str pre fold diﬀerence
of 5.55, with a p value of <0.0001 (Table 8 of the Supporting
Information)]. Further, the level of postsynaptic expression of
this isoform was signiﬁcantly higher in the striatum than in the
postsynaptic fraction in each of the other three brain regions
[Figure 4D; Str post/CTX post fold diﬀerence of 5.47, with a p
value of <0.0001; Str post/CRB post fold diﬀerence of 8.41,
with a p value of <0.0001; Str post/Hippo post fold diﬀerence
of 3.13, with a p value of <0.0001 (Table 8 of the Supporting
Information)]. Gγ12 was unique among the isoforms in that
although no regional diﬀerences were observed, the level of
subcellular expression was signiﬁcantly higher in postsynaptic
fractions across all brain regions than in presynaptic fractions
(Figure 4E). There were brain region and fraction eﬀects for
Gγ12 [CTX post/CTX pre fold diﬀerence of 2.81, with a p value
of <0.01; CRB post/CRB pre fold diﬀerence of 3.16, with a p
value of <0.001; Hippo post/Hippo pre fold change of 5.36,
with a p value of <0.05; Str post/Str pre fold diﬀerence of
10.46, with a p value of <0.001 (Table 9 of the Supporting
Information)]. Finally, Gγ13 exhibited both regional and
subcellular diﬀerences in localization, and there were both
brain region and fraction eﬀects for this isoform (ANOVA p
value of <0.0001 in both cases). The level of expression of this
isoform in the cortex was found to be signiﬁcantly higher in
both the pre- and postsynaptic fractions than in the
hippocampus and striatum [Figure 4F; CTX pre/Hippo pre
fold diﬀerence of 4.03, with a p value of <0.05; CTX pre/Str
pre fold diﬀerence of 8.76, with a p value of <0.01; CTX post/
Str post fold diﬀerence of 2.86, with a p value of <0.05 (Table
10 of the Supporting Information)]. Similarly, the level of
expression of Gγ13 was found to be signiﬁcantly higher in the
postsynaptic fraction of the cerebellum than in the postsynaptic
fractions of the hippocampus and striatum [Figure 4F; CRB
post/Hippo post fold diﬀerence of 2.38, with a p value of <0.01;
CRB post/Str post fold diﬀerence of 3.06, with a p value of
<0.01 (Table 10 of the Supporting Information)]. No
signiﬁcant diﬀerences in subcellular localization were observed
in the cortex, hippocampus, or striatum, but the level of
expression was signiﬁcantly higher in the postsynaptic fraction
within the cerebellum than in the presynaptic fraction [Figure
4F; CRB post/CRB pre fold diﬀerence of 2.22, with a p value of
<0.01 (Table 10 of the Supporting Information)].
■ DISCUSSION
G protein βγ subunits are known to play essential roles in
cellular communication via complex regulatory mechanisms.
Increasingly, studies are demonstrating that receptors and
eﬀectors preferentially interact with unique complements of
Gβγ isoforms,23,24,43,71−73 suggesting that precise regulation of
expression and localization is important74 for maintaining the
ﬁdelity of signaling pathways. Transcript expression suggests
these isoforms are distributed across many brain regions, but
less is known about protein localization as a high level of
sequence identity makes development of subunit speciﬁc
antibodies diﬃcult. The novel application of MRM techniques
to this question allows accurate identiﬁcation and quantiﬁcation
of endogenous Gβγ subunits from complex mixtures of brain
tissue. With this approach, we demonstrate brain region speciﬁc
diﬀerences in the protein expression patterns of individual G
protein β and γ isoforms in pre- and postsynaptic fractions. We
employed an LRP method to evaluate the relative expression of
each isoform, as SID methods that include labeled internal
protein standards for each peptide being monitored are cost-
prohibitive given the number of peptides to be analyzed. Zhang
et al.64 recently showed that an LRP method is a reasonable
alternative to SID as it is well suited for comparing relative
protein levels and is capable of detecting the same signiﬁcant
diﬀerences in biological samples. Application of this technique
to this study is a ﬁrst required step toward a more complete
understanding of speciﬁcity in Gβγ signaling. The observed
diﬀerences suggest neuronal cells would be able to channel
information diﬀerentially through signaling complexes and
second-messenger pathways in diﬀerent brain regions.
Diﬀerential Expression and Distribution of Gβγ
Isoforms between Brain Regions. Several studies have
demonstrated that Gβ and Gγ isoforms show diﬀerential
patterns of expression throughout the CNS. Although the data
obtained in those studies are in general agreement with those
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presented here, ours is the ﬁrst to provide a comprehensive
map of their protein distribution to distinct subcellular
fractions; previously, only Gβ1 has been reported in both the
presynaptic active zone55 and PSD.56 Gβ1 is expressed
ubiquitously throughout the brain,35,39 correlating well with
our ﬁndings that this isoform could be detected at comparable
levels within pre- and postsynaptic fractions across most of the
brain regions examined (Figure 3A). A similar range of levels of
expression was observed for Gβ2 and Gβ4 (Figure 3B,C). In
vitro data show that Gβ1, Gβ2, and Gβ4 can all pair with
numerous Gγ isoforms, as well as couple to a variety of
receptors and eﬀectors.75 While this implies involvement in a
wide range of signaling pathways and supports the broad
distribution we observed, their function in vivo is poorly
understood. What is known is that Gβ1 plays an important role
in neural development; its removal is perinatally lethal, and
pups exhibit reduced cortical thickness, reduced brain volume,
and impaired neural progenitor cell proliferation.76 Compara-
tively, Gβ2 may play a role in neuronal excitability as mice in
which Gγ3 is lost exhibit a severe seizure phenotype and a
reduction in the level of Gβ2 within the cortex, cerebellum, and
striatum.25,77 Further, knockdown studies demonstrate Gβ1,
Gβ2, and Gβ4 each signal downstream of speciﬁc GPCRs found
throughout the CNS.78,79 The extensive expression patterns we
observed for each isoform may thus be expected, as a broad
distribution would be required to support such diverse signaling
pathways.
In contrast to the other Gβ isoforms, expression of Gβ5 was
seen exclusively within the striatum, as levels within the cortex,
cerebellum, and hippocampus were below the limit of detection
(Figure 3D). This result diﬀers from previously published
reports that suggested a wide distribution similar to that of the
other Gβ isoforms.35,39,40 While we cannot rule out that such
disparity reﬂects physiological diﬀerences in the expression of
the protein product or diﬀerential post-translational processing
between brain regions, such a limited distribution may also
correspond to the interaction of Gβ5 with regulators of G
protein signaling (RGS) proteins. Gβ5 forms a stable obligate
dimer with members of the RGS R7 subfamily to modulate Gi-
mediated signal transduction pathways.80−84 One member,
RGS9-2, is enriched in the striatum, and the RGS9-2−Gβ5
complex is localized to the membrane through its interaction
the R7 family binding protein (R7BP).82,85−87 Conversely,
RGS7−Gβ5 complexes are found intracellularly throughout the
CNS.82,87 This may explain why, in this study, Gβ5 could be
detected only in the striatum. Our fractionation protocol aimed
to enrich the presynaptic active zone membrane fraction as well
as the PSD membrane fraction, while cytosolic fractions were
not analyzed. The Gβ5−RGS9-2 association with the plasma
membrane in the striatum is consistent with our detection of
Gβ5 in this region. Further, as R7BP and RGS9-2 colocalize
predominantly to postsynaptic membranes,86,88 enrichment of
Gβ5 in postsynaptic fractions within this region would be
expected (Figure 3D). If, in other brain regions, Gβ5 is
primarily complexed with RGS7 and found intracellularly, it
would not have been detected in this study as these fractions
were not analyzed. Further eﬀorts will be needed to determine
whether Gβ5 can be detected in cytosolic fractions to address
this hypothesis.
In comparison, the Gγ subunits show more varied expression
patterns; however, with the exception of Gγ5 and Gγ11, each
isoform could be clearly identiﬁed within each of the four brain
regions examined (Figure 4). Although immunohistochemical
studies have localized particular isoforms to the CNS in general,
a detailed examination of their expression to brain regions and
cell types has been limited to transcript levels.35,89 For some Gγ
isoforms, transcript expression reported previously correlates
well with the localization patterns observed in this study,
whereas in others it diﬀers notably. For example, using in situ
hybridization, Betty et al.35 showed strong expression of Gγ7
within the striatum, followed closely by the hippocampus,
cortex, and cerebellum, similar to what is seen in this study
(Figure 4D). Conversely, the authors reported Gγ4 to be
strongly expressed in the hippocampus and cerebellum but
more weakly in the striatum, whereas our analyses show the
opposite: strong expression in the striatum but signiﬁcantly
lower levels in the cerebellum (Figure 4C). It is diﬃcult to say
whether these diﬀerences reﬂect physiological eﬀects relating to
the expression of the protein product or possible protein
modiﬁcations that were not identiﬁed in this study. One factor
that may contribute to the disparities, however, is that this
study examined expression patterns at subcellular levels. In
comparison, previous in situ studies were able to evaluate Gγ
expression at only the cellular level, which would have included
both the soma and the nerve terminals. Thus, direct
comparison between such studies is not possible.
Little is known about the subcellular distribution of Gγ
isoforms within the CNS. Moricano et al.55 localized Gγ3 to the
presynaptic active zone, but subcellular localization patterns for
the remaining Gγ isoforms have not been previously evaluated.
The wide discrepancy in expression patterns within subcellular
fractions and across the four brain regions could reﬂect unique
contributions by each isoform to unique signaling pathways.
This is supported by the distinct phenotypes observed when Gγ
isoforms are genetically knocked out. In the case of Gγ3, genetic
deletion results in mice with an increased susceptibility to
seizures, as well as resistance to diet-induced obesity, implying a
role in neuronal excitability and regulation of appetite or
metabolism.24,77 Loss of Gγ3 suppresses the expression of Gβ1
and Gβ2 within the cortex, cerebellum, and striatum,
implicating a Gβ1/2γ3 dimer within these regions and in
agreement with our expression results (Figure 4B). It is
noteworthy that signiﬁcant enrichment of Gγ3 was observed in
the postsynaptic fraction of the striatum. Although further
eﬀorts are needed to understand the physiological consequen-
ces of this ﬁnding, one possibility may be related to the activity
of μ-opioid receptors within this region. The loss of Gγ3 results
in defective signaling through the μ-opioid receptor.77 Within
the striatum, these receptors have been implicated in the
hedonic response to food90,91 and act via a postsynaptic
mechanism.92 As a result, the enrichment seen in the
postsynaptic fraction of the striatum could represent an
important signaling cascade activated by μ-opioid receptors
and involving the Gγ3 subunit; further eﬀorts will be needed to
explore this possibility. In comparison, animals in which Gγ7
has been knocked out exhibit an enhanced startle response,
which may result from defective D1 dopamine and A2A
adenosine receptor activation within the striatum.25,93,94 This
correlates well with our ﬁnding, and previously published
reports,35,95 that Gγ7 is most strongly expressed in the striatum
(Figure 4D). While further eﬀorts will be needed to conﬁrm the
exact mechanism, given that both D1 and A2A receptors are
localized primarily to dendritic spines,96,97 the fact that we
observed signiﬁcant enrichment of Gγ7 within the postsynaptic
fraction (Figure 4D) suggests a predominately postsynaptic role
for Gγ7 within this region.
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Although no genetically modiﬁed animals are available for
Gγ2 and Gγ4, knockdown of these isoforms oﬀers insight into
the expression patterns we observed. Early work by
Kalkbrenner et al.98 demonstrated that silencing of endogenous
Gγ2 and Gγ4 in cultured cells reduced the extent of galanin-
induced calcium inhibition. More recently, a role in nociception
was suggested for Gγ2, as injection of antisense oligonucleotides
into the CNS of mice attenuated the analgesic eﬀects of opioid,
cannabinoid, and adrenergic agonists.99,100 Such a range of
eﬀector interactions would be expected to contribute to the
observed localization patterns. Galanin, cannabinoid, and
adrenergic receptors all exhibit a broad distribution in the
CNS,101 while opioid receptor subtypes are highly expressed
within the striatum and cortex.102−104 As a result, if Gγ2 and
Gγ4 acted via these receptors in vivo, the wide distribution we
observed (Figure 4A,C) could exist because their expression
parallels that of their target GPCRs.
Finding Gγ13 within each of the brain regions we examined
was exciting as this G protein has largely been reported in
sensory tissues, where it is required for olfactory and gustatory
transduction.105 While transcript expression within the brain
closely mirrors our results106,107 (Figure 4F), little is known
about the function of this isoform in the CNS. Gγ13 has been
shown to interact with the third PDZ domain of PSD-95 via a
PDZ binding C-terminal sequence, and the two proteins can be
eﬃciently pulled down together from brain lysates.108 It is
possible that this association aids in targeting the G protein to
particular subcellular locations and/or facilitates interactions
with appropriate eﬀectors such as GIRK channels and
PLCβ2,
106 accounting for the stronger expression of Gγ13 in
postsynaptic fractions (Figure 4F).
Additional Factors That May Contribute to Diﬀer-
ential Expression Patterns. In addition to signaling
requirements, other factors are likely to inﬂuence the observed
localization patterns. A striking feature from our data was that
while most G protein isoforms were found in all four brain
regions, prominent diﬀerences were observed between regions.
Such disparity may reﬂect G protein expression within
individual cell types as well as patterns of innervation to
speciﬁc brain regions. For example, the striatum is composed
largely of γ-aminobutyric acid (GABA)-containing medium
spiny neurons yet receives excitatory inputs from the cortex and
dopaminergic innervations from the midbrain.109,110 Gluta-
matergic pyramidal neurons predominate in the hippocampus,
but this region also receives monoamine and cholinergic inputs
from the median raphe,111,112 locus coeruleus,113 and basal
forebrain.114 In contrast, the cerebellum could be considered
more homogeneous as Purkinje cells represent the sole output
of the cerebellar cortex, but even these integrate excitatory
aﬀerent pathways as well as strong inhibitory GABAergic
inputs.115 Such diversity in cell type and innervation patterns
may provide clues about why diﬀerences in G protein
expression patterns were observed between brain regions as
well as subcellular fractions. This is supported by early work by
Betty et al.35 and Liang et al.,39 as well as the more recent eﬀort
or Schwindinger et al.25 Thus, G protein expression within
particular cell types, as well as the innervation within a brain
region, would inﬂuence the results seen in our study.
Synaptosomal preparations and subcellular fractionation
techniques such as those described do not allow Gβγ
expression patterns to be evaluated endogenously within
speciﬁc cell types. However, with recent advances in
optogenetics, transgenic mice that express ﬂuorescent proteins
under the control of cell-type speciﬁc promoters are becoming
available. By taking advantage of these mice in future studies,
we will be able to evaluate localization patterns within speciﬁc
neuron populations and subcellular fractions to determine if
these factors contribute to the expression of speciﬁc isoforms.
■ SUMMARY
In summary, we report that G protein β and γ isoforms exhibit
distinct patterns of localization across brain regions as well as
subcellular fractions. This is particularly interesting as it implies
speciﬁc functions for individual isoforms in modulating cellular
responses and signaling cascades. Further eﬀorts will be
necessary to determine the relevance of these patterns of
distribution and to evaluate which Gβγ dimers exist
endogenously and the contribution each makes to cellular
communication.
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(23) Kleuss, C., Scherübl, H., Hescheler, J., Schultz, G., and Wittig, B.
(1992) Different β subunits determine G-protein interaction with
transmembrane receptors. Nature 358, 424−426.
(24) Wang, Q., Mullah, B. K., and Robishaw, J. D. (1999) Ribozyme
approach identifies a functional association between the G protein β1γ7
subunits in the β-adrenergic receptor signaling pathway. J. Biol. Chem.
274 (24), 17365−17371.
(25) Schwindinger, W. F., Giger, K. E., Betz, K. S., Stauffer, A. M.,
Sunderlin, E. M., Sim Selley, L. J., Selley, D. E., Bronson, S. K., and
Robishaw, J. D. (2004) Mice with Deficiency of G Protein γ3 Are Lean
and Have Seizures. Mol. Cell. Biol. 24 (17), 7758−7768.
(26) Schwindinger, W. F., Mirshahi, U. L., Baylor, K. A., Sheridan, K.
M., Stauffer, A. M., Usefof, S., Stecker, M. M., Mirshahi, T., and
Robishaw, J. D. (2012) Synergistic roles for G-protein γ3 and γ7 in
seizure susceptibility as revealed in double knock out mice. J. Biol.
Chem. 287 (10), 7121−7133.
(27) Zhang, J.-H., Pandey, M., Seigneur, E. M., Panicker, L. M., Koo,
L., Schwartz, O. M., Chen, W., Chen, C.-K., and Simonds, W. F.
(2011) Knockout of G protein β5 impairs brain development and
causes multiple neurologic abnormalities in mice. J. Neurochem. 119
(3), 544−554.
(28) Downes, G. B., Copeland, N. G., Jenkins, N. A., and Gautam, N.
(1998) Structure and mapping of the G protein γ3 subunit gene and a
divergently transcribed novel gene, Gng3lg. Genomics 53, 220−230.
(29) Fisher, K. J., and Aronson, N. N., Jr. (1992) Characterization of
the cDNA and genomic sequence of a G protein γ subunit (γ5). Mol.
Cell. Biol. 12 (4), 1585−1591.
(30) Gautam, N., Northup, J., Tamir, H., and Simon, M. I. (1990) G
protein diversity is increased by associations with a variety of γ
subunits. Proc. Natl. Acad. Sci. U.S.A. 87, 7973−7977.
(31) Kalyanaraman, S., Kalyanaraman, V., and Gautam, N. (1995) A
brain-specific G protein γ subunit. Biochem. Biophys. Res. Commun. 216
(1), 126−132.
(32) Morishita, R., Fukada, Y., Kokame, K., Yoshizawa, T., Masuda,
K., Niwa, M., Kato, K., and Asano, T. (1992) Identification and
isolation of common and tissue specific geranylgeranylated γ subunits
of guanine-nucleotide-binding regulatory proteins in various tissues.
Eur. J. Biochem. 210, 1061−1069.
(33) Watson, A. J., Katz, A., and Simon, M. I. (1994) A fifth member
of the mammalian G protein β-subunit family. Expression in brain and
activation of the β2 isotype of phospholipase C. J. Biol. Chem. 269 (35),
22150−22156.
(34) Weizsac̈ker, E. V., Strathmann, M. P., and Simon, M. I. (1992)
Diversity among the β subunits of heterotrimeric GTP-binding
proteins: Characterization of a novel β subunit cDNA. Biochem.
Biophys. Res. Commun. 183 (1), 350−356.
(35) Betty, M., Harnish, S. W., Rhodes, K. J., and Cockett, M. I.
(1998) Distribution of heterotrimeric G-protein β and γ subunits in
the rat brain. Neuroscience 85 (2), 475−486.
(36) Cali, J. J., Baleueva, E. A., Rybalkin, I., and Robishaw, J. D.
(1992) Selective tissue distribution of G protein γ subunits, including a
new form of the γ subunits identified by cDNA cloning. J. Biol. Chem.
267 (33), 24023−24027.
Biochemistry Article
dx.doi.org/10.1021/bi500091p | Biochemistry 2014, 53, 2329−23432340
(37) Jones, P. G., Lombardi, S. J., and Cockett, M. I. (1998) Cloning
and tissue distribution of the human G protein β5 cDNA. Biochim.
Biophys. Acta 1402, 288−291.
(38) Largent, B. L., Jones, D. T., Reed, R. R., Pearson, C. A., and
Snyder, S. H. (1988) G protein mRNA mapped in rat brain by in situ
hybridization. Proc. Natl. Acad. Sci. U.S.A. 85, 2864−2868.
(39) Liang, J.-J., Cockett, M., and Khawaja, X. Z. (1998)
Immunohistochemical localization of G protein β1, β2, β3, β4, β5, and
γ3 subunits in the adult rat brain. J. Neurochem. 71, 345−355.
(40) Zhang, J.-H., Lai, Z., and Simonds, W. (2000) Differential
expression of the G protein β5 gene: Analysis of mouse brain,
peripheral tissues, and cultured cell lines. J. Neurochem. 75, 393−403.
(41) Morishita, R., Ueda, H., Kato, K., and Asano, T. (1998)
Identification of two forms of the γ subunit of G protein, γ10 and γ11, in
bovine lung and their tissue distribution in the rat. FEBS Lett. 428, 85−
88.
(42) Robishaw, J. D., Kalman, V. K., Moomaw, C. R., and Slaughter,
C. A. (1989) Existence of two γ subunits of the G proteins in brain. J.
Biol. Chem. 264 (27), 15758−15761.
(43) Bigler Wang, D., Shermann, N. E., Shannon, J. D., Leonhardt, S.
A., Mayeenuddin, L. H., Yeager, M., and McIntire, W. E. (2011)
Binding of β4γ5 by adenosine A1 and A2A receptors determined by
stable isotope labeling with amino acids in cell culture and mass
spectrometry. Biochemistry 50, 207−220.
(44) Bai, F., and Witzmann, F. A. (2007) Synaptosome Proteomics.
Subcell. Biochem. 43, 77−98.
(45) Boyd-Kimball, D., Castegna, A., Sultana, R., Poon, H. F.,
Petroze, R., Lynn, B. C., Klein, J. B., and Butterfield, D. A. (2005)
Proteomic identification of proteins oxidized by Aβ(1−42) in
synaptosomes: Implications for Alzheimer’s disease. Brain Res. 1044,
206−215.
(46) Burre,́ J., and Volknandt, W. (2007) The synaptic vesicle
proteome. J. Neurochem. 101, 1448−1462.
(47) Fountoulaki, M. (2004) Application of proteomics technologies
in the investigation of the brain. Mass Spectrom. Rev. 23, 231−258.
(48) Li, K. W., Hornshaw, M. P., Van der Schors, R. C., Watson, R.,
Tate, S., Casetta, B., Jimenez, C. R., Gouwenberg, Y., Gundelfinger, E.
D., Smalla, K.-H., and Smit, A. B. (2004) Proteomics analysis of rat
brain postsynaptic density. J. Biol. Chem. 279 (2), 987−1002.
(49) Liberatori, S., Canas, B., Tani, C., Bini, L., Buonocore, G.,
Godovac-Zimmermann, J., Mishra, O. P., Delivoria-Papadopoulos, M.,
Bracci, R., and Pallini, V. (2004) Proteomic approach to the
identification of voltage-dependent anion channel protein isoforms
in guinea pig brain synaptosomes. Proteomics 4, 1335−1340.
(50) Mallei, A., Giambelli, R., Gass, P., Racagni, G., Mathe,́ A. A.,
Vollmayr, B., and Popoli, M. (2011) Synaptoproteomics of learned
helpless rats involve energy metabolism and cellular remodeling
pathways in depressive-like behavior and antidepressant response.
Neuropharmacology 60, 1243−1253.
(51) Stasyk, T., and Huber, L. A. (2004) Zooming in: Fractionation
strategies in proteomics. Proteomics 4, 3704−3716.
(52) Witzmann, F. A., Arnold, R. J., Bai, F., Hrncirova, P., Kimpei, M.
W., Mechref, Y. S., McBride, W. J., Novotny, M. V., Pedrick, N. M.,
Ringham, H. N., and Simon, J. R. (2005) A proteomic survey of rat
cerebral cortical synaptosomes. Proteomics 5, 2177−2201.
(53) Gylys, K. H., Fein, J. A., Yang, F., Wiley, D. J., Miller, C. A., and
Cole, G. M. (2004) Synaptic changes in Alzheimer’s disease: Increased
amyloid-β and gliosis in surviving terminal is accompanied by
decreased PSD-95 fluorescence. Neurobiology 165 (5), 1809−1817.
(54) Morciano, M., Burre,́ J., Corvey, C., Karas, M., Zimmermann,
H., and Volknandt, W. (2005) Immunoisolation of two synaptic
vesicle pools from synaptosomes: A proteomic analysis. J. Neurochem.
95, 1732−1745.
(55) Morciano, M., Beckhaus, T., Karas, M., Zimmermann, H., and
Volknandt, W. (2009) The proteome of the presynaptic active zone:
From docked synaptic vesicles to adhesion molecules and maxi-
channels. J. Neurochem. 108, 662−667.
(56) Satoh, K., Takeuchi, M., Oda, Y., Deguchi-Tawarada, M.,
Sakamato, Y., Matsubara, K., Nagasu, Y., and Takai, Y. (2002)
Identification of activity-regulated proteins in the postsynaptic density
fraction. Genes Cells 7, 187−197.
(57) Volknandt, W., and Karas, M. (2012) Proteomic analysis of the
presynaptic active zone. Exp. Brain Res. 217, 449−461.
(58) Boja, E. S., and Rodriguez, H. (2012) Mass spectrometry-based
targeted quantitative proteomics: Achieving sensitive and reproducible
detection of proteins. Proteomics 12 (8), 1093−1100.
(59) Shi, T., Su, D., Liu, T., Tang, K., Camp, D. G., II, Qian, W. J.,
and Smith, R. D. (2012) Advancing the sensitivity of selected reaction
monitoring-based targeted quantitative proeomics. Proteomics 12 (8),
1074−1092.
(60) Mazzoni, M. R., Malinski, J. A., and Hamm, H. E. (1991)
Structural analysis of rod GTP binding protein, Gt. Limited proteolytic
digestion pattern of Gt with four proteases defines monoclonal
antibody epitope. J. Biol. Chem. 266 (21), 14072−14081.
(61) Phillips, G. R., Huang, J. K., Wang, Y., Tanaka, H., Shapiro, L.,
Zhang, Q., Shan, W., Arndt, K., Frank, M., Gordon, R. E., Gawinowicz,
A., Zhao, Y., and Colman, D. R. (2001) The presynaptic particle web:
Ultrastructure, composition, dissolution, and reconstitution. Neuron
32, 63−77.
(62) Eng, J. K., McCormack, A. L., Yates, I., and John, R. (1994) An
approach to correlate tandem mass spectral data of peptides with
amino acid sequenes in a protein database. J. Am. Soc. Mass Spectrom.
5, 976−989.
(63) MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M.,
Finney, G. L., Frewan, B., Kern, R., Tabb, D. L., Liebler, D. C., and
MacCoss, M. J. (2010) Skyline: An open source document editor for
creating and analyzing targeted proteomics experiments. Bioinformatics
26 (7), 966−968.
(64) Zhang, H., Liu, Q., Zimmerman, L. J., Ham, A. J., Slebos, R. J.
C., Rahman, J., Kikuchi, T., Massion, P. P., Carbone, D. P., Billheimer,
D., and Liebler, D. C. (2011) Methods for peptide and protein
quantitation by liquid chromatography-multiple reaction monitoring
mass spectrometry. Mol. Cell. Proteomics 10 (6), M110.006593.
(65) Tobin, V., Schwab, Y., Lelos, N., Onaka, T., Pittman, Q. J., and
Ludwig, M. (2012) Expression of exocytosis proteins in rat supraoptic
nucleus neurones. J. Neuroendocrinol. 24 (4), 629−641.
(66) Daimon, M., Sato, H., Kain, W., Tada, K., Takase, K., Karasawa,
S., Wada, K., Kameda, W., Susa, S., Oizumi, T., Kayama, T.,
Muramatsu, M., and Kato, T. (2013) Association of the G-protein
β3 subunit gene polymorphism with the incidence of cardiovascular
disease independent of hypertension: The Funagata study. J. Hum.
Hypertens. 27, 612−616.
(67) Ryba, N. J. P., and Tirindelli, R. (1995) A novel GTP-binding
protein g-subunit, Gγ8, is expressed during neurogenesis in the
olfactory and vomeronasal neuroepithelia. J. Biol. Chem. 270 (12),
6757−6767.
(68) Hurley, J. B., Fong, H. K. W., Teplow, D. B., Dreyer, W. J., and
Simon, M. I. (1984) Isolation and characterization of a cDNA clone
for the γ subunit of bovine retinal transducin. Proc. Natl. Acad. Sci.
U.S.A. 81, 6948−6952.
(69) Kilpatrick, E. L., and Hildebrandt, J. D. (2007) Sequence
dependence and differential expression of Gγ5 subunit isoforms of the
heterotrimeric G proteins variably processed after prenylation in
mammalian cells. J. Biol. Chem. 282 (19), 14038−14047.
(70) Kirkpatrick, D. S., Gerber, S. A., and Gygi, S. P. (2005) The
absolute quantification strategy: A general procedure for the
quantification of proteins and post translational modificiations.
Methods 35, 265−273.
(71) Stehno-Bittel, L., Krapivinsky, G., Krapivinsky, L., Perez-Terzic,
C., and Clapham, D. E. (1995) The G protein βγ subunit transduces
the muscarinic receptor signal for Ca2+ release in Xenopus oocytes. J.
Biol. Chem. 270 (50), 30068−30074.
(72) Lindorfer, M. A., Myung, C. S., Savino, Y., Yasuda, H., Khazan,
R., and Garrison, J. C. (1998) Differential activity of the G protein
β5γ2 subunit at receptors and effectors. J. Biol. Chem. 273 (51),
34429−34436.
(73) Lim, W. K., Myung, C. S., Garrison, J. C., and Neubig, R. R.
(2001) Receptor-G protein gamma specificity: γ11 shows unique
Biochemistry Article
dx.doi.org/10.1021/bi500091p | Biochemistry 2014, 53, 2329−23432341
potency for A1 adenosine and 5HT1A receptors. Biochemistry 40 (35),
10532−10541.
(74) Hamid, E., Church, E., Wells, C. A., Zurawski, Z., Hamm, H. E.,
and Alford, S. (2014) Modulation of neurotransmision by GPCRs is
dependant upon the microarchitecture of the primed vesicle complex.
J. Neurosci. 34 (1), 260−274.
(75) Albert, P. R., and Robillard, L. (2002) G protein specificity:
Traffic direction required. Cell. Signalling 14, 407−418.
(76) Okae, I., and Iwakura, Y. (2010) Neural tube defects and
impaired neural progenitor cell proliferation in Gβ1-deficient mice.
Dev. Dyn. 239, 1089−1101.
(77) Schwindinger, W. F., Borrell, B. M., Waldman, L. C., and
Robishaw, J. D. (2009) Mice lacking the G protein γ3-subunit show
resistance to opioids and diet induced obesity. Am. J. Physiol. 297,
R1494−R1502.
(78) Dippel, E., Kalkbrenner, F., Wittig, B., and Schultz, G. (1996) A
heterotrimeric G protein complex couples the muscarinic m1 receptor
to phospholipase C-β. Proc. Natl. Acad. Sci. U.S.A. 93, 1391−1396.
(79) Mahmoud, S., Yun, J. K., and Ruiz-Velasco, V. (2012) Gβ2 and
Gβ4 participate in the opioid and adrenergic receptor-mediated Ca
2+
channel modulation in rat sympathetic neurons. J. Physiol. 590, 4673−
4689.
(80) Zachariou, V., Georgescu, D., Sanchez, N., Rahman, Z.,
DeLeone, R., Berton, O., Neve, R. L., Sim-Selley, L. J., Selley, D. E.,
Gold, S. J., and Nestler, E. J. (2003) Essential role for RGS9 in opiate
action. J. Neurosci. 29, 13656−13661.
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